Clinical Trials Directory

Trials / Completed

CompletedNCT05190861

Evaluation of Droplet Digital PCR Rapid Detection Method and Precise Diagnosis and Treatment for Suspected Sepsis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,032 (actual)
Sponsor
Huashan Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Sepsis is a significant public health concern worldwide, with high morbidity and mortality. With regard to a targeted antimicrobial treatment strategy, the earliest possible pathogen detection is of crucial importance. Until now, culture-based detection methods represent the diagnostic gold standard, although they are characterized by numerous limitations. Culture-independent molecular diagnostic procedures may represent a promising alternative. In particular, droplet digital PCR (ddPCR) is a novel one-step PCR assay that achieves higher accuracy and sensitivity in detecting causing pathogens in patients with bloodstream infections.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTdroplet digital PCR methodThe droplet digital PCR method can detect nucleic acids from the most common pathogens (approximately 90%) responsible for BSIs according to Chinet2020 and takes about 4 hours to perform, reporting within the first 24h of suspected sepsis/septic shock.
DIAGNOSTIC_TESTblood cultureBlood culture is a conventional microbiological method of pathogen detection. Results from blood cultures are usually not available until 24 to 72 hours after sampling.

Timeline

Start date
2021-12-29
Primary completion
2023-12-29
Completion
2023-12-29
First posted
2022-01-13
Last updated
2025-07-11

Locations

9 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05190861. Inclusion in this directory is not an endorsement.